Skip to main content
. 2017 Dec 14;8:2120. doi: 10.1038/s41467-017-02214-8

Fig. 3.

Fig. 3

Tissue-specific promoter transgenic lines. a NL9 line expressing GFP under the muscle-specific promoter of the MYH6 gene. Zoom in—detailed images of the body wall (top) and stylet (bottom); In situ—whole-mount in situ hybridization expression pattern of MYH6 transcript. b NL22 line expressing GFP under the gut-specific promoter of the APOB gene. Zoom in—detailed images of the gut side (top) and distal tip (bottom); In situ—whole-mount in situ hybridization expression pattern of the APOB transcript. c NL21 line expressing GFP under the testis-specific promoter of the ELAV4 gene. Zoom in—detailed images of the testis (top) and seminal vesicle (bottom); In situ—whole-mount in situ hybridization expression pattern of the ELAV4 transcript. d NL23 line expressing GFP under the ovary-specific promoter of the CABP7 gene. Zoom in—detailed image of the ovary and developing egg; In situ—whole-mount in situ hybridization expression pattern of the CABP7 transcript. e NL24 line expressing in a single construct NeonGreen under the testis-specific promoter of the ELAV4 gene and Scarlet-I under the ovary-specific promoter of the CABP7 gene. Zoom in—detailed images of the testis (top) and ovary (bottom) regions. FITC—FITC channel; DsRed—DsRed channel; BF—bright-field. Scale bars are 100 μm